Sulforaphane for Stage IV Cancer
Also known as: Broccoli sprout extract, SFN
Sulforaphane's Nrf2 activation and HDAC inhibition provide both cancer prevention and potential treatment-sensitization effects.
Mechanism of Action
Sulforaphane activates Nrf2-ARE pathway (Phase II detoxification), inhibits HDAC enzymes (restoring tumor suppressor gene expression), induces cancer cell apoptosis through ROS generation, inhibits NF-κB, and reduces cancer stem cell self-renewal through Wnt/β-catenin modulation.
General mechanism: Isothiocyanate from cruciferous vegetables. Nrf2-ARE activator, HDAC inhibitor, NF-κB suppressor, cancer cell apoptosis inducer.
Current Evidence
Clinical trials for cancer prevention (prostate, breast) show biomarker changes consistent with anti-cancer activity. Broccoli sprout extract standardized to sulforaphane is well-tolerated. Combination with standard therapy is being explored.
Clinical Status: Phase I/II for cancer prevention. Biomarker studies positive. Available as supplement (broccoli sprout extract).
Safety Profile
Very safe. Well-tolerated from dietary sources and supplements. Mild GI effects at high doses. Myrosinase co-administration enhances bioavailability.
Key Research Questions
- Can sulforaphane sensitize tumors to checkpoint inhibitor therapy through HDAC-mediated antigen presentation enhancement?
- What is the optimal dosing regimen for cancer prevention vs. treatment adjunct?
Frequently Asked Questions
How does sulforaphane fight cancer?
Sulforaphane activates Nrf2, the master antioxidant transcription factor, and inhibits HDAC enzymes (epigenetic anti-cancer effect). It induces Phase II detoxification enzymes, reduces NF-κB inflammation, and induces apoptosis in cancer cells while protecting normal cells. Broccoli sprouts contain 20-100x more sulforaphane precursor than mature broccoli.
Sulforaphane supplement vs broccoli sprouts
3-day-old broccoli sprouts contain 20-100x the sulforaphane precursor (glucoraphanin) of mature broccoli. Supplements standardized to glucoraphanin with myrosinase enzyme provide consistent dosing. Clinical trials use 40-60mg sulforaphane equivalent daily.